Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP.
Journal: Annals of clinical and translational neurology
Published: June 19, 2021
Clinical trial of a humanized anti-IL-2/IL-15 receptor β chain in HAM/TSP.
Journal: Annals of clinical and translational neurology
Published: April 17, 2019
Development of neurologic diseases in a patient with primate T lymphotropic virus type 1 (PTLV-1).
Journal: Retrovirology
Published: April 12, 2016
Common γ-chain blocking peptide reduces in vitro immune activation markers in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 19, 2015
Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum.
Journal: The Journal of biological chemistry
Published: April 24, 2015
In vivo imaging of spinal cord atrophy in neuroinflammatory diseases.
Journal: Annals of neurology
Published: April 07, 2014
Epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional suppression of Tregs.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
Published: January 27, 2014
Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutations.
Journal: Journal of neurovirology
Published: January 13, 2014
Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals.
Journal: Retrovirology
Published: November 28, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026